Valuation: Abbott Laboratories

Market Cap 18TCr 16TCr 15TCr 14TCr 26TCr 17,44900Cr 26TCr 1,80500Cr 72TCr 9,17900Cr 69TCr 67TCr 28,94600Cr P/E 2026 *
35.1x
P/E 2027 * 25.6x
Enterprise Value 21TCr 19TCr 17TCr 15TCr 29TCr 19,68500Cr 29TCr 2,03700Cr 82TCr 10,35500Cr 78TCr 76TCr 32,65600Cr EV / Sales 2026 *
4.15x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.44%
Yield 2027 * 2.6%
1 day+3.51%
1 week+4.42%
Current month+8.26%
1 month+8.26%
3 months+0.85%
6 months+14.56%
Current year-11.94%
1 week 11.4
Extreme 11.4
11.8
1 month 10.6
Extreme 10.6
11.8
Current year 9.2
Extreme 9.2
14.8
1 year 9.2
Extreme 9.2
14.8
3 years 9.2
Extreme 9.2
16
5 years 9.2
Extreme 9.2
16
10 years 9.2
Extreme 9.2
16
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+3.51%+4.42% - - 18TCr
+1.56%+2.41%-14.82%+14.19% 18TCr
-6.38%-4.98%-20.90%+11.15% 12TCr
-0.59%+1.18%+6.12%+37.97% 12TCr
+3.42%+1.71%-42.32%+9.52% 9.14TCr
+0.09%-0.05%-3.04%+78.44% 6.31TCr
-0.46%+0.42%+8.19%+82.97% 5.58TCr
-0.23%-0.52%+10.31%-21.19% 5.4TCr
-4.30%-1.64%-12.30%+39.06% 4.54TCr
+0.58%+2.00%-1.07%-6.43% 3.44TCr
Average -0.28%-0.05%-7.76%+27.30% 8.48TCr
Weighted average by Cap. +0.20%+0.10%-10.60%+25.24%

Financials

2026 *2027 *
Net sales 5TCr 4.47TCr 4.12TCr 3.73TCr 6.97TCr 4,74400Cr 7.1TCr 49TCr 20TCr 2,49600Cr 19TCr 18TCr 7,87000Cr 5.35TCr 4.79TCr 4.41TCr 4TCr 7.47TCr 5,08300Cr 7.61TCr 53TCr 21TCr 2,67400Cr 20TCr 20TCr 8,43100Cr
Net income 564.32Cr 505.41Cr 464.9Cr 421.23Cr 787.39Cr 54TCr 802.13Cr 5.54TCr 2.23TCr 28TCr 2.12TCr 2.07TCr 89TCr 766.31Cr 686.3Cr 631.29Cr 572Cr 1.07TCr 73TCr 1.09TCr 7.53TCr 3.02TCr 38TCr 2.88TCr 2.81TCr 1,20700Cr
Net Debt 2.36TCr 2.11TCr 1.94TCr 1.76TCr 3.29TCr 2,23700Cr 3.35TCr 23TCr 9.29TCr 1,17600Cr 8.84TCr 8.65TCr 3,71000Cr 2.01TCr 1.8TCr 1.66TCr 1.5TCr 2.81TCr 1,91200Cr 2.86TCr 20TCr 7.94TCr 1,00600Cr 7.56TCr 7.4TCr 3,17200Cr
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change
30/26/30 €11.80 +3.51%
29/26/29 €11.40 -1.72%
28/26/28 €11.60 0.00%
27/26/27 €11.60 +1.75%
26/26/26 €11.40 +0.88%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
106.20USD
Average target price
118.52USD
Spread / Average Target
+11.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories